Richard B. Parad, MD, MPH
|Hospital Title||Assistant in Medicine|
|Academic Title||Associate Professor of Pediatrics|
Connors Center for Women and Newborns, Rm CWN418
Department of Newborn Medicine
Brigham and Women’s Hospital
75 Francis Street
Boston, MA 02115
Dr. Parad is interested in translational molecular genetics (genotype-phenotype relationships and screening) and clinical research (particularly with regard to respiratory diseases in newborns, including CLD and CF), with a goal to optimize early detection, treatment and outcome of disease.
About Richard Parad
- Wesleyan University, BA (Biology)
- University of California, San Diego School of Medicine, M.D.
- Harvard School of Public Health, M.P.H (Quantitative Methods)
- Borowitz D, Parad RB, Sharp JS, Sabadosa KA, Robinson KA, Rock MJ, Farrell PN, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond . J Peds. 2009;155(6, Supplement 1):S106-S116.
- Keiles S, Koepke R, Parad R, Kharrazi M. Impact of IVS8-(TG)m(T)n haplotype on immunoreactive trypsinogen and sweat chloride levels in a cohort of hypertrypsinogenemic newborns with genotype ΔF508/5T identified by California cystic fibrosis newborn screening. Journal of Cystic Fibrosis. 2012 (in press).
Parad RB, Allred EN, Rosenfeld WN, Davis JM. Decreased Retinopathy of Prematurity in Extremely Low Gestational Age Newborns Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD). Neonatology. 2012 (in press)